User contributions
From WikiPathways
(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)
- 14:16, 2 July 2021 Homo sapiens:Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway
- 13:44, 2 July 2021 Homo sapiens:Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway
- 03:24, 29 June 2021 Homo sapiens:Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway
- 01:55, 29 June 2021 Homo sapiens:Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway
- 01:51, 29 June 2021 Homo sapiens:Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway (Changed format of pathway)
- 17:35, 22 June 2021 Homo sapiens:Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway
- 17:29, 22 June 2021 Homo sapiens:Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway (Change font size)
- 17:22, 22 June 2021 Homo sapiens:Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway (Ontology Term : 'DOID:10763' removed !)
- 17:20, 22 June 2021 Homo sapiens:Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway (Change titel name and changed interactions)
- 06:59, 17 June 2021 Homo sapiens:Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway (increased font size and removed interaction between cGMP and hypertension)
- 03:05, 2 June 2021 Homo sapiens:Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway (Included literature and interplay between NRF2 and NF-kB)
- 03:55, 1 June 2021 Homo sapiens:Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway (Added literature references)
- 12:23, 28 May 2021 N Homo sapiens:Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway (New pathway)
- 08:34, 12 May 2021 N RTokaai (Initial user page) (top)
- 08:34, 12 May 2021 N RTokaai (Initial user page) (top)
(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)